논문실적
Home › 연구실적 › 논문실적
- 410Impact of Body Weight and Combined UGT1A1 and NR1I2 Polymorphisms on Dolutegravir Pharmacokinetics Among Thai People Living with HIV: A Population Pharmacokinetic Analysis
Chanruang A, Birnbaum AK, Illamola SM, Sirilun S, Chupradit S, Ubolyam S, Hiranburana N, Cho YS, Shin JG, Avihingsanon A, Punyawudho B · Pharmaceutics. 18(10):1245 / 2026.10 · 2026 cPMTb
- 409From Invisible to Enrolled: How Artificial Intelligence Is Reshaping Clinical Trial Recruitment
Ahn S · Pharmaceut Med / 2026.09 · 2026 IPPM
- 408Rapid fecal lipidome profiling in inflammatory bowel disease: A novel approach for exploratory disease molecular characterization and therapeutic monitoring
Thu NQ, Kim DW, An VT, Dat LHB, Tien NTN, Yu SJ, Nguyen DN, Kim DH, Lee HS, Long NP · J Pharm Biomed Anal. 282:117687 / 2026.07 · 2026 IPPM
- 407Multi-omics analysis reveals mitochondrial dysfunction-driven oxidative stress pathways in Caenorhabditis elegans exposed to 2,2-bis(chloromethyl) trimethylene bis[bis(2-chloroethyl) phosphate] (V6)
Ahn J, Tien NTN, Thu NQ, Lee SK, Kim DH, Park SM, Long NP, Kim HM · J Pharm Biomed Anal. 280:117617 / 2026.06 · 2026 IPPM
- 406Bridging the Gap Between Pharmacogenomic Discovery and Clinical Implementation: Insights from Selected Studies on Inter-Individual Variability in Drug Response
Lee SJ · J Pers Med. 16(4):221 / 2026.04 · 2026 IPPM
- 405Modulation of Macrophage Inflammatory Responses by UDP-Glucuronosyltransferase-Mediated PGE2 Glucuronidation
Lee D, Cho HY, Ahn S, Cho YS, Kim DH, Shin JG, Lee SJ · J Pers Med. 16(3):160 / 2026.03 · 2026 IPPM
- 404Enhancing history-taking education through GPT-4-based virtual patients and automated assessment: a study of medical student perceptions
Byun J, Kim H, Lim J, Choi J, Ahn S · Korean J Med Educ. 38(1):64-73 / 2026.03 · 2026 IPPM
- 403NAT2 Polymorphisms and Antituberculosis-Induced Hepatotoxicity in Thai People Living With HIV: Insights From a Pharmacogenetic-Pharmacokinetic Cohort Study
Hiranburana N, Sophonphan J, Kerr SJ, Ubolyam S, Usawakidwiree W, Torvorapanit P, Suwanpimolkul G, Phaisal W, Chariyavilaskul P, Cho YS, Shin JG, Mahasirimongkol S, Avihingsanon A · J Infect Dis. 233(2):287-297 / 2026.02 · 2026 IPPM
- 402Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure
Jayanti RP, Cho YS, Soedarsono S, Kim HJ, Kang J, Kim J, Oh JY, Kang BH, Ha JH, Kim JW, Mertaniasih NM, Kusmiati T, Permatasari A, Yuliwulandari R, Kim R, Seong HJ, Ghim JL, Kim DH, Shin JG, cPMTb · PLoS One. 21(1):e0340133 / 2026.01 · 2026 IPPM
- 401Are artificial intelligence (AI) agents ready for medicine and biomedical research? A narrative review
Ahn S · J Yeungnam Med Sci. 43:40 / 2026 · 2026 IPPM
- 400Effects of resveratrol on CYP450-derived arachidonic acid metabolites and mRNA gene expression in human endothelial HUVEC cells
Jarrar YB, Al-Sayed Ahmad M, Althaher A, Nasser W, Khirfan F, Shraim AS, Lee SJ · J Complement Integr Med. 23(1):120-127 / 2025.12 · 2025 IPPM
- 399From Bainbridge to bedside: applying automation insights to medical curriculum and assignment design in the artificial intelligence era
Ahn S · Korean J Med Educ. 37(4):519-524 / 2025.12 · 2025 IPPM
- 398Acid-suppressive effect of tegoprazan 12.5 mg BID: a phase 1 comparative study with tegoprazan 25 mg QD and famotidine 20 mg BID
Kim HS, Choi YK, Oh M, Cho YS, Ghim JL · Transl Clin Pharmacol. 33(4):238-251 / 2025.12 · 2025 IPPM
- 397Identification of UDP-Glucuronosyltransferase mRNA in human platelets: differential levels in smokers and non-smokers
Jarrar Y, Almansour M, Abulebdeh D, Nasser W, Jarrar Q, Abudahab S, Lee SJ · Platelets. 36(1):2536306 / 2025.12 · 2025 IPPM
- 396The Association Between Genetic Polymorphisms of UGT1A1, ABCG2, and NR1I2 and Dolutegravir Pharmacokinetic Parameters in Thai People Living with HIV
Chanruang A, Birnbaum AK, Sirilun S, Chupradit S, Ubolyam S, Hiranburana N, Cho YS, Shin JG, Avihingsanon A, Punyawudho B · Pharmaceutics. 17(11):1499 / 2025.11 · 2025 cPMTb